Article, Early Access,
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort
Affiliations
- [1] Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macau, Peoples R China [NORA names: China; Asia, East];
- [2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, 2 Fuxue Lane, Wenzhou 325000, Peoples R China [NORA names: China; Asia, East];
- [3] Jiangnan Univ, Med Ctr, Dept Nephrol, Wuxi, Peoples R China [NORA names: China; Asia, East];
- [4] Nantong Univ, Affiliated Wuxi Clin Coll, Wuxi, Peoples R China [NORA names: China; Asia, East];
- [5] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China [NORA names: China; Asia, East];
(... more)
Abstract
Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.
Keywords
N-terminal propeptide of type 3 collagen,
chronic kidney disease,
liver fibrosis,
metabolic dysfunction-associated fatty liver disease,
metabolic dysfunction-associated steatotic liver disease,
risk prediction